|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-30
|
$1,889,710
|
$75,588
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-11
|
$334,932
|
$16,747
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Virotherapy for Relapsed Refractory Multiple Myeloma
|
5R01CA125614-03
|
|
$0
|
DISPENZIERI, ANGELA
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
Z01 CP010183-00580
|
$179,292
|
$8,965
|
Anderson, William
|
DCEG (NCI)
|
|
VCU Minority-Based CCOP
|
5U10CA052784-18
|
$577,110
|
$5,771
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-20
|
$1,758,769
|
$70,351
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
Z01 BC 005673
|
$1,225,024
|
$245,005
|
Keefer, Larry
|
CCR (NCI)
|
|
Use of CCI-779 in multiple myeloma
|
1R21CA121464-01A2
|
$319,950
|
$319,950
|
LICHTENSTEIN, ALAN
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
1P30CA134274-01
|
$1,463,613
|
$43,908
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Iowa CALGB Institutional Grant
|
5U10CA047642-21
|
$110,413
|
$5,521
|
VAENA, DANIEL
|
UNIVERSITY OF IOWA
|
|
Type 1 MAGE vaccine immunotherapy for multiple myeloma
|
5K01CA115917-03
|
$159,624
|
$159,624
|
Cho, Hearn
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Tumor maintenance and development in mouse models
|
5U01CA105492-05
|
$464,773
|
$153,375
|
VARMUS, HAROLD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Tumor Banking for the Southwest Oncology Group
|
5U24CA114748-04
|
$1,061,839
|
$106,184
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Transplant Models
|
Z01 BC 010957
|
$530,539
|
$53,054
|
Gress, Ronald
|
CCR (NCI)
|
|
Transcriptional Regulation of Myeloma Cell Growth
|
5R01CA098550-05
|
$224,093
|
$224,093
|
WICKREMA, AMITTHA
|
UNIVERSITY OF CHICAGO
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-25
|
$721,858
|
$7,219
|
SCHAEFER, PAUL
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S1
|
$91,948
|
$3,678
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S2
|
$49,383
|
$1,975
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S3
|
$83,152
|
$3,326
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-15
|
$5,084,061
|
$203,362
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Molecular Basis for Bortezomib Activity
|
5R01CA129009-02
|
$304,166
|
$304,166
|
STEWART, A
|
MAYO CLINIC COLL OF MED, MAYO CLINIC AZ
|
|
The Incidence of Breast and other Cancers among Female Flight Attendants
|
Z01 CP010133-04077
|
$1,270
|
$25
|
Linet, Martha
|
DCEG (NCI)
|
|
The Genetics of Susceptibility to Mouse Plasma Cell Tumors
|
Z01 BC 010008
|
$304,687
|
$24,375
|
Mock, Beverly
|
CCR (NCI)
|
|
The Development of Stat3 Inhibitors
|
5R01CA096652-06
|
$347,886
|
$173,943
|
MCMURRAY, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Brooklyn Minority-Based Community Clinical Oncology*
|
5U10CA114671-02
|
$554,189
|
$5,542
|
Solomon, William
|
SUNY DOWNSTATE MEDICAL CENTER
|
|
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Therapy
|
Z01 SC 010288
|
$942,078
|
$47,104
|
Fowler, Daniel
|
CCR (NCI)
|
|
Targeting the Mitochondria to Treat Lymphoma and Myeloma
|
5K23CA109613-04
|
$131,450
|
$65,725
|
Evens, Andrew
|
NORTHWESTERN UNIVERSITY
|
|
Targeting myeloma via dendritic cells
|
7R01CA109465-04
|
$309,925
|
$309,925
|
DHODAPKAR, MADHAV
|
YALE UNIVERSITY
|
|
Targeting Epigenomics in Myeloid Neoplasms
|
5K24CA111717-04
|
$147,360
|
$73,680
|
GORE, STEVEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeting cell trafficking as a new therapeutic modality for Multiple Myeloma
|
1R01CA133799-01A1
|
$352,995
|
$352,995
|
Ghobrial, Irene
|
DANA-FARBER CANCER INSTITUTE
|
|
Targeted Therapy of B-cell Malignancies
|
5P01CA103985-04
|
$1,618,062
|
$161,806
|
GOLDENBERG, DAVID
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
|
Sweden and Denmark linked registries on hospital discharges and subsequent cancer
|
Z01 CP010183-00560
|
$4,450
|
$222
|
Anderson, William
|
DCEG (NCI)
|
|
SUNY Downstate Medical Center Minority-Based Community Clinical Oncology Program
|
3U10CA114671-02S1
|
$100,000
|
$1,000
|
Solomon, William
|
SUNY DOWNSTATE MEDICAL CENTER
|
|
Studies on Monoclonal Gammopathies
|
5P01CA062242-13
|
$1,439,826
|
$1,439,826
|
Jelinek, Diane
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Stroger Hospital of Cook County, Department of Surgery,*
|
3U10CA095867-07S1
|
$99,993
|
$1,000
|
ZAREN, HOWARD
|
HEKTOEN INSTITUTE FOR MEDICAL RESEARCH
|
|
Stroger Hospital of Cook County, Department of Surgery,*
|
5U10CA095867-07
|
$706,480
|
$7,065
|
ZAREN, HOWARD
|
HEKTOEN INSTITUTE FOR MEDICAL RESEARCH
|
|
Stanford University Cancer Center
|
3P30CA124435-02S1
|
$80,833
|
$808
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Stanford University Cancer Center
|
5P30CA124435-02
|
$1,572,967
|
$15,730
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
St. Vincent Hospital Regional Cancer Center CCOP
|
5U10CA095968-07
|
$648,991
|
$6,490
|
SAPHNER, THOMAS
|
ST. VINCENT HOSPITAL
|
|
SPORE in Myeloma
|
2P50CA100707-06
|
$2,300,000
|
$2,300,000
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S1
|
$115,875
|
$1,159
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S2
|
$247,200
|
$2,472
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S3
|
$92,700
|
$927
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S4
|
$76,478
|
$765
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
5P30CA023100-24
|
$4,005,660
|
$40,057
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-22
|
$1,906,536
|
$19,065
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Sioux Community Cancer Consortium
|
5U10CA035103-25
|
$944,268
|
$9,443
|
TSCHETTER, LOREN
|
SANFORD CLINIC
|
|
Sensitivity Multiple Myeloma Cells to mTOR Inhibitors
|
5R01CA111448-04
|
$188,765
|
$188,765
|
LICHTENSTEIN, ALAN
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
Selective Targeting of MEK and AKt in Lymphoma and Myeloma Apoptosis
|
5K22CA128882-02
|
$167,400
|
$83,700
|
CAREY, GREGORY
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Selective Inhibition of HDAC6 in Cancer Therapy
|
1K08CA128972-01A1
|
$139,240
|
$139,240
|
BRADNER, JAMES
|
DANA-FARBER CANCER INSTITUTE
|
Total relevant funding to Multiple Myeloma for this search: $41,541,846
|